A	O
proteomic	B:C1327760
evaluation	I:C1327760
of	O
urinary	O
changes	O
associated	O
with	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
.	O

The	O
urinary	O
proteome	B:C0751973
of	O
patients	O
undergoing	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
(	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
)	O
may	O
provide	O
important	O
insights	O
into	O
systemic	O
and	O
renal	B:C0184571
changes	I:C0184571
associated	O
with	O
the	O
procedure	B:C0087111
.	O

Such	O
information	O
may	O
ultimately	O
provide	O
a	O
basis	O
to	O
differentiate	O
changes	O
or	O
properties	O
associated	O
with	O
the	O
development	O
of	O
acute	B:C2609414
kidney	I:C2609414
injury	I:C2609414
.	O

While	O
mass	B:C0037813
spectrometry	I:C0037813
(	O
mass	B:C0037813
spectrometry	I:C0037813
)	O
analysis	B:C0936012
offers	O
the	O
potential	O
for	O
in	O
-	O
depth	O
compositional	O
analysis	B:C0936012
it	O
is	O
often	O
limited	O
in	O
coverage	O
and	O
relative	O
quantitation	O
capacity	O
.	O

The	O
aim	O
of	O
this	O
study	B:C0008972
was	O
to	O
develop	O
a	O
process	O
flow	O
for	O
the	O
preparation	O
and	O
comparison	O
of	O
the	O
intraoperative	O
urinary	O
proteome	B:C0751973
.	O

Urines	B:C0042036
were	O
collected	O
from	O
patients	O
at	O
the	O
start	O
of	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
and	O
1-h	O
into	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
.	O

Pooled	O
samples	O
(	O
n	O
=	O
5	O
)	O
from	O
each	O
time	O
point	O
were	O
processed	O
using	O
a	O
modified	B:C1720914
Filter	I:C1720914
Assisted	I:C1720914
Sample	I:C1720914
Preparation	I:C1720914
protocol	I:C1720914
.	O

The	O
resulting	O
peptides	B:C0030956
were	O
analyzed	O
by	O
2D	B:C0872318
-	I:C0872318
LC	I:C0872318
-	I:C0872318
MS	I:C0872318
/	O
mass	B:C0037813
spectrometry	I:C0037813
and	O
by	O
1D	B:C0872318
-	I:C0872318
LC	I:C0872318
-	I:C0872318
MS	I:C0872318
/	O
mass	B:C0037813
spectrometry	I:C0037813
SWATH	B:C0022885
(	O
Sequential	B:C0022885
Window	I:C0022885
acquisition	I:C0022885
of	I:C0022885
All	I:C0022885
Theoretical	I:C0022885
fragment	I:C0022885
ion	I:C0022885
spectra	I:C0022885
)	O
.	O

The	O
2D	B:C0872318
-	I:C0872318
LC	I:C0872318
-	I:C0872318
MS	I:C0872318
/	O
mass	B:C0037813
spectrometry	I:C0037813
analysis	B:C0936012
identified	O
1324	O
proteins	B:C0033684
in	O
the	O
two	O
pools	B:C1509144
,	O
of	O
which	O
744	O
were	O
quantifiable	O
.	O

The	O
SWATH	B:C0022885
approach	I:C0022885
provided	O
quantitation	O
for	O
730	O
proteins	B:C0033684
,	O
552	O
of	O
which	O
overlapped	O
with	O
the	O
common	O
population	O
from	O
the	O
2D	B:C0449859
-	I:C0449859
IDA	I:C0449859
results	O
.	O

Intensity	B:C0010101
correlation	I:C0010101
filtering	B:C0242481
between	O
the	O
two	O
methods	B:C0449309
gave	O
475	O
proteins	B:C0033684
for	O
biological	O
interpretation	O
.	O

Proteins	B:C0033684
displaying	O
greater	O
than	O
threefold	O
changes	O
(	O
>	O
log2	O
1.59	O
)	O
at	O
1	O
-	O
hour	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
relative	O
to	O
the	O
initiation	O
of	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
(	O
26	O
down	B:C0013081
-	I:C0013081
regulated	I:C0013081
and	O
22	O
up	B:C0041904
-	I:C0041904
regulated	I:C0041904
)	O
were	O
selected	O
for	O
further	O
analysis	B:C0936012
.	O

Up	B:C0041904
-	I:C0041904
regulated	I:C0041904
proteins	B:C0033684
were	O
enriched	O
in	O
GO	B:C1138831
terms	O
related	O
to	O
humoral	B:C1155229
immune	I:C1155229
response	I:C1155229
,	O
predominantly	O
innate	O
immunity	O
(	O
C4b	B:C1448577
,	O
lactotransferrin	B:C0022942
,	O
protein	B:C4281719
S100	I:C4281719
-	I:C4281719
A8	I:C4281719
,	O
cathelicidin	B:C0671062
,	O
myeloperoxidase	B:C0027021
)	O
and	O
extracellular	B:C0015350
matrix	I:C0015350
reorganization	B:C1511632
(	O
e.g.	O
MMP	B:C0165519
-	I:C0165519
9	I:C0165519
)	O
.	O

This	O
study	B:C0008972
describes	O
a	O
scheme	O
for	O
processing	B:C0037793
urine	B:C0042036
from	O
patients	O
undergoing	O
cardiopulmonary	B:C0007202
bypass	I:C0007202
for	O
mass	B:C0037813
spectrometry	I:C0037813
-	O
based	O
analysis	B:C0002778
.	O

The	O
introduction	O
of	O
SWATH	B:C0022885
into	O
the	O
workflow	O
offers	O
a	O
sample	O
and	O
instrument	O
sparing	O
approach	O
to	O
obtaining	O
consistent	O
in	B:C1303103
-	I:C1303103
depth	I:C1303103
sample	I:C1303103
analysis	I:C1303103
.	O

The	O
design	O
of	O
the	O
methodology	B:C0086912
is	O
such	O
that	O
it	O
can	O
be	O
readily	O
applied	O
to	O
large	O
numbers	O
of	O
clinical	O
samples	O
with	O
the	O
potential	O
for	O
automation	O
.	O

The	O
results	B:C0456984
also	O
suggest	O
that	O
activation	B:C1817386
of	I:C1817386
the	I:C1817386
innate	I:C1817386
immune	I:C1817386
responses	I:C1817386
occur	O
during	O
cardiac	B:C1536078
bypass	I:C1536078
surgery	I:C1536078
.	O

